Novel biodegradable lipid nano complex for siRNA delivery significantly improving the chemosensitivity of human colon cancer stem cells to paclitaxel. - Wikidata - wikimedia - TriplyDB

Novel biodegradable lipid nano complex for siRNA delivery significantly improving the chemosensitivity of human colon cancer stem cells to paclitaxel.

Novel biodegradable lipid nano complex for siRNA delivery significantly improving the chemosensitivity of human colon cancer stem cells to paclitaxel.

http://www.wikidata.org/entity/Q30872690

about

Cancer nanotheranostics: improving imaging and therapy by targeted delivery across biological barriers.Cancer stem cells and drug resistance: the potential of nanomedicine Micelle-like nanoparticles as carriers for DNA and siRNA Can nanomedicines kill cancer stem cells?Nanomedicine strategies for sustained, controlled, and targeted treatment of cancer stem cells of the digestive system Current prospects for RNA interference-based therapies Identification of glycogen synthase kinase 3α as a therapeutic target in melanoma Galectin-1 knockdown improves drug sensitivity of breast cancer by reducing P-glycoprotein expression through inhibiting the Raf-1/AP-1 signaling pathway Synthesis and characterization of lipid-polymer hybrid nanoparticles with pH-triggered poly(ethylene glycol) shedding.PI3K/Akt inhibition and down-regulation of BCRP re-sensitize MCF7 breast cancer cell line to mitoxantrone chemotherapy.P-glycoprotein silencing with siRNA delivered by DOPE-modified PEI overcomes doxorubicin resistance in breast cancer cells Hyaluronic acid-functionalized polymeric nanoparticles for colon cancer-targeted combination chemotherapy.Co-delivery of camptothecin and curcumin by cationic polymeric nanoparticles for synergistic colon cancer combination chemotherapy.Cancer stem cell theory: therapeutic implications for nanomedicine.Cancer stem cells in breast cancer.Targeting Cancer Stem Cells with Nanoparticle-Enabled Therapies.Recently identified and potential targets for colon cancer treatment.Colon cancer stem cells: implications in carcinogenesis.Recent attempts at RNAi-mediated P-glycoprotein downregulation for reversal of multidrug resistance in cancer.Recent progress in copolymer-mediated siRNA delivery.Cancer multidrug resistance: mechanisms involved and strategies for circumvention using a drug delivery system.Nanomaterials for targeted drug delivery to cancer stem cells.Delivery of therapeutics using nanocarriers for targeting cancer cells and cancer stem cells.Nanocarrier-mediated drugs targeting cancer stem cells: an emerging delivery approach.Understanding the colon cancer stem cells and perspectives on treatment.Photochemical activation of drugs for the treatment of therapy-resistant cancers.Cancer stem cells in human digestive tract malignancies.The Implications and Future Perspectives of Nanomedicine for Cancer Stem Cell Targeted Therapies.Targeting CD133(+) laryngeal carcinoma cells with chemotherapeutic drugs and siRNA against ABCG2 mediated by thermo/pH-sensitive mesoporous silica nanoparticles.Nanoparticle-mediated co-delivery of chemotherapeutic agent and siRNA for combination cancer therapy.Drug resistance and cancer stem cells: the shared but distinct roles of hypoxia-inducible factors HIF1α and HIF2α.Polymers in the Co-delivery of siRNA and Anticancer Drugs for the Treatment of Drug-resistant Cancers.Degradable Polyethylenimine-Based Gene Carriers for Cancer Therapy.Lipid modified triblock PAMAM-based nanocarriers for siRNA drug co-delivery.Growth inhibition and chemosensitization of human carcinoma cells by human serum albumin-coated liposomal antisense oligodeoxyribonucleotide against bcl-2.Phospholipid-polyethylenimine conjugate-based micelle-like nanoparticles for siRNA delivery.Functionalised nanomaterials for eradication of CSCs, a promising approach for overcoming tumour heterogeneity.Targeted photodynamic therapy as potential treatment modality for the eradication of colon cancer and colon cancer stem cells.Cytotoxicity Enhancement in Breast Cancer Cells with Carbonate Apatite-Facilitated Intracellular Delivery of Anti-Cancer Drugs.FMSP-Nanoparticles Induced Cell Death on Human Breast Adenocarcinoma Cell Line (MCF-7 Cells): Morphometric Analysis.

P2860

Q26830028-C7456D86-1630-4C2A-83CC-E14859373A2A Q26998993-1804FFE9-D6C4-4B32-86A6-4FE01D3C2DE1 Q27001558-1D48A1B2-9247-4BD0-84F9-4264B101B91D Q27022017-7BAB8E1A-6F91-4594-BC66-070B34BD2DC2 Q28079367-111CD32D-CEC5-413F-A07C-D7904CF2B3FA Q28235733-045B648C-332B-4725-8E64-C86AAF66F0C9 Q33569998-4F310367-6EF5-45B7-B43C-94AF0D8978DB Q33648764-127B6AE4-33B3-4347-84ED-A44EB30075C9 Q35193987-A7267CD2-7AC9-4EC1-9BFB-E662F9C76385 Q35763457-DA7411A4-B658-4AA9-9136-0012D7A5D5C3 Q36174338-3D7BDEE4-9952-4216-91F7-415CE2DEFB47 Q36201940-036C967E-9DDF-44B3-BF18-B61F600C6FD5 Q36326103-65A9F337-B355-404E-98CC-8A198DFA2D54 Q36659443-B9B9E581-D4E4-4277-BC4D-7909145E99D1 Q37129887-49DB15C5-2AC8-4D50-AAAF-C8AFFAED7C01 Q37419338-EAB953A2-3A40-4D47-9133-F16FD629E718 Q37763104-56AFC232-3CAD-47F1-93C9-D6444799E7FB Q37825224-35C88C38-FE4B-42D1-8CDB-A556DB3941F1 Q37869444-0D9B72B0-B4FB-4663-8B26-3D8E66DF6F4D Q38023545-FDB26448-6F3E-49AE-96AA-E67387FC23D8 Q38165880-6637ABF0-EF1B-4376-B8D7-6928FE479855 Q38201740-F34FABB6-06E4-4798-AE06-E35C98CBBA71 Q38322466-83AC2862-FC70-43EA-A5F6-9B39DA04B90F Q38324456-05A38286-0D14-4B2A-A9FB-2E37BC0CA212 Q38356774-8A83D791-CF9E-46B8-BD49-BD3F0697A780 Q38409528-86F512C0-403A-4436-B654-D444E0FB2FFF Q38601789-DB6BD307-DEA1-4B84-A2BA-FCC9FC820C31 Q38645695-259D7A59-F0EB-4E3C-B4E8-B88D61A58C79 Q38836547-615E409D-BE5F-4014-812F-21E35C46A590 Q38874499-9AE3DF34-F51E-4926-AE78-1E7240FEE177 Q38997399-A066EDDA-7932-457B-96C9-C8C76C3DF7F7 Q39125540-8710FFBE-E438-45B1-835F-19B5D6BFE737 Q39177170-3B829AC6-809D-43A4-A4BB-13E616F5EFEB Q39247726-6838B508-F261-4286-9200-2DDAFBACA01F Q39288970-578C2957-E267-430E-8A2D-46137F1FC506 Q42283679-E9828143-059B-4524-8CCA-09507559EF9D Q47370661-602BCB4C-56C2-420C-8DFC-ECCB908016C0 Q49486366-7A36A80F-A47C-4006-9714-ED51F6622287 Q55289862-EECC32F7-5AA7-407D-A44F-94EFF5F3970C Q55399254-5E9A58C7-A78F-4AEF-A9ED-5CCD8ACCC284

P2860

Novel biodegradable lipid nano complex for siRNA delivery significantly improving the chemosensitivity of human colon cancer stem cells to paclitaxel.

http://www.wikidata.org/entity/Q30872690

description

2009 nî lūn-bûn

@nan

2009 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Novel biodegradable lipid nano ...... ncer stem cells to paclitaxel.

@ast

Novel biodegradable lipid nano ...... ncer stem cells to paclitaxel.

@en

type

label

Novel biodegradable lipid nano ...... ncer stem cells to paclitaxel.

@ast

Novel biodegradable lipid nano ...... ncer stem cells to paclitaxel.

@en

prefLabel

Novel biodegradable lipid nano ...... ncer stem cells to paclitaxel.

@ast

Novel biodegradable lipid nano ...... ncer stem cells to paclitaxel.

@en

P1433

Q30872690-00099601-D0BE-47B2-AC71-556307E27CB3

P1476

Q30872690-FAB95EA9-4BCE-44FF-A67C-0538FC39C1CA

P2093

Q30872690-244459C3-F48F-4E98-931B-61564AFE3BFD

Q30872690-3A0BDEF1-90BC-42E0-9BD1-663EC465DE38

Q30872690-45D0BD8B-3A6F-41A8-B8FA-654C4129301B

Q30872690-4EA09B39-3C5C-4832-B621-371267D875E3

Q30872690-8AB475A8-8304-430B-B6A0-7AD79018140F

Q30872690-8D4613C5-E021-4CC8-9FA1-13193D7DEEDC

Q30872690-91DC6B02-F26D-478D-950D-20F530A359CE

Q30872690-9DDD5E2E-EF43-41CE-B155-F612E06E1CCD

Q30872690-B6B908B2-57FA-4C8F-84F0-22CCF63A9946

Q30872690-BC9E67FC-AF37-47DC-B7DE-338B7FE26830

P304

Q30872690-6C18AA5E-137E-4A4D-A3E1-3A60D889213C

P31

Q30872690-B8574BB4-3B14-4CF6-B883-F9DE9C91EB54

P356

Q30872690-ECE806EB-846D-4512-95C7-2D7E0F3A0E2B

P407

Q30872690-B5CC8604-FDCD-491B-BBB1-E8B5EF634043

P433

Q30872690-32387648-F2A7-43D0-BEA4-0BEB81FAEE6B

P478

Q30872690-412814F6-25D9-407D-AEA6-D846745B19D5

P577

Q30872690-623F06EC-F2AF-48AA-8674-736EC34591BA

P698

Q30872690-A67799D2-51F0-4852-98C3-AFD8CF8B3D60

P921

Q30872690-95A740A2-1455-4C23-B795-8084562B2D36

P356

J.JCONREL.2009.08.013

P1433

Journal of Controlled Release

P1476

Novel biodegradable lipid nano ...... ncer stem cells to paclitaxel.

@en

P2093

Changxing Liu

http://www.w3.org/2001/XMLSchema#string

David Gough

http://www.w3.org/2001/XMLSchema#string

Gang Zhao

http://www.w3.org/2001/XMLSchema#string

Jian Liu

http://www.w3.org/2001/XMLSchema#string

Keisaku Okada

http://www.w3.org/2001/XMLSchema#string

Lei Yu

http://www.w3.org/2001/XMLSchema#string

Loren Perelman

http://www.w3.org/2001/XMLSchema#string

Nianchun Ma

http://www.w3.org/2001/XMLSchema#string

Padmanabh Chivukula

http://www.w3.org/2001/XMLSchema#string

Zongyou Chen

http://www.w3.org/2001/XMLSchema#string

P304

277-283

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.JCONREL.2009.08.013

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

140

http://www.w3.org/2001/XMLSchema#string

P577

2009-08-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19699770

http://www.w3.org/2001/XMLSchema#string

P921